APA (7th ed.) Citation

Parveen, N., Chiu, W., Shen, L., Chou, R., Sun, C., & Yu, C. (2023). The Anti-Cancer Activity of Pentamidine and Its Derivatives (WLC-4059) Is through Blocking the Interaction between S100A1 and RAGE V Domain. Biomolecules (2218-273X), 13(1), 81. https://doi.org/10.3390/biom13010081

Chicago Style (17th ed.) Citation

Parveen, Nuzhat, Wei-Jung Chiu, Li-Ching Shen, Ruey-Hwang Chou, Chung-Ming Sun, and Chin Yu. "The Anti-Cancer Activity of Pentamidine and Its Derivatives (WLC-4059) Is Through Blocking the Interaction Between S100A1 and RAGE V Domain." Biomolecules (2218-273X) 13, no. 1 (2023): 81. https://doi.org/10.3390/biom13010081.

MLA (9th ed.) Citation

Parveen, Nuzhat, et al. "The Anti-Cancer Activity of Pentamidine and Its Derivatives (WLC-4059) Is Through Blocking the Interaction Between S100A1 and RAGE V Domain." Biomolecules (2218-273X), vol. 13, no. 1, 2023, p. 81, https://doi.org/10.3390/biom13010081.